39,650 Shares in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Acquired by Algert Global LLC

Algert Global LLC acquired a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the fourth quarter, HoldingsChannel reports. The institutional investor acquired 39,650 shares of the medical instruments supplier’s stock, valued at approximately $753,000.

Other large investors have also recently made changes to their positions in the company. Riverview Trust Co bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth approximately $26,000. MassMutual Private Wealth & Trust FSB grew its position in shares of DENTSPLY SIRONA by 648.4% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock worth $27,000 after buying an additional 1,232 shares during the last quarter. UMB Bank n.a. grew its position in shares of DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after buying an additional 564 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in shares of DENTSPLY SIRONA by 700.0% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier’s stock worth $33,000 after buying an additional 1,568 shares during the last quarter. Finally, Quarry LP grew its position in shares of DENTSPLY SIRONA by 25.7% in the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier’s stock worth $72,000 after buying an additional 780 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors.

Insider Buying and Selling at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,142 shares of the firm’s stock in a transaction dated Monday, March 3rd. The stock was purchased at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the purchase, the director now directly owns 81,971 shares of the company’s stock, valued at $1,353,341.21. This trade represents a 22.66% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.50% of the stock is owned by company insiders.

DENTSPLY SIRONA Stock Down 0.6%

Shares of NASDAQ:XRAY opened at $15.81 on Monday. The stock has a fifty day simple moving average of $14.36 and a two-hundred day simple moving average of $17.54. The stock has a market capitalization of $3.15 billion, a price-to-earnings ratio of -7.64, a PEG ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA Inc. has a 12-month low of $12.16 and a 12-month high of $28.69. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.14. The business had revenue of $879.00 million during the quarter, compared to analysts’ expectations of $854.75 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm’s quarterly revenue was down 7.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.42 earnings per share. On average, research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 4.05%. The ex-dividend date was Friday, March 28th. DENTSPLY SIRONA’s payout ratio is -14.10%.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on XRAY. Wells Fargo & Company cut their price objective on DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating on the stock in a research report on Friday, February 28th. Morgan Stanley lowered DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 price target on the stock. in a research report on Tuesday, April 15th. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday. Finally, UBS Group dropped their price target on DENTSPLY SIRONA from $27.00 to $25.00 and set a “buy” rating on the stock in a research report on Friday. Eleven investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA currently has an average rating of “Hold” and a consensus price target of $20.27.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.